secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001558370-25-008817
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve 108,612-share increase to Dogwood equity incentive plan at annual meeting
--------------------------------------------------------------------------------

- Plan amendment raises shares reserved from 82,500 to 191,112; approved with 275,020 for, 6,482 against, 1,284 abstain.
- Seven directors elected: De La Rosa, Duncan, Keefer, Thomas, Toh, Whitley, Yu. No director changes announced.
- Ratification of Forvis Mazars as auditor for FY2025: 888,808 for, 31,671 against, 1,116 abstain.
- Annual meeting quorum: 921,595 shares (48.22% voting power).
- Amendment includes one-year minimum vesting for future grants, with limited exception for new hires.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837025008817/0001558370-25-008817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837025008817/dwtx-20250618x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-008817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer